Abstract:
The high prevalence of arterial hypertension (AH) and concomitant obesity in young patients is not only a medical but also a social problem. It is
important to develop additional modern approaches to the management of
young patients with AH and obesity, which will increase the effectiveness
of existing antihypertensive (anti-AH) medical therapy and prevent early
damage of target organs and complications.
The purpose of the research was to evaluate the antihypertensive efficacy
of the proposed complex treatment and its impact on quality of life in young
patients with AH and obesity (or overweight).
